Yili Chuanning Bio
3013018.660.93% ( +0.08 )
Yili Chuanning Bio (301301)
Yili Chuanning Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research, development, and industrialization of bio-fermentation technolog...
- Open
- 8.56
- High
- 8.75
- Low
- 8.55
- Prev. Close
- 8.58
- Volume
- 111.34K
- Turnover
- 96.32M
- Avg Price
- 8.65
- Bid/Ask Ratio
- --
- Amplitude
- 2.33%
- 52wk High
- 12.77
- Volume Ratio
- 0.64
- Turnover Ratio
- 1.79%
Yili Chuanning Bio Analyst Rating
View MoreForecast & Rating
May 9, 2026Price forecast
¥14.0061.66%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- London Stock Exchange · 2 days ago, 05:06 AM
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
- benzinga_article · Jul 24 at 05:25 AM
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
- Zhitong · Oct 27, 2025 at 05:33 AM
Yili Chuanning Bio: Net profit in the third quarter was 157 million yuan, a year-on-year decrease of 49.44%
- Zhitong · Sep 11, 2025 at 10:54 PM
Yili Chuanning Bio has been approved to register 1 billion yuan medium-term notes
- Zhitong · Aug 31, 2025 at 10:03 PM
KELUN PHARMA: With the arrival of the peak season in the fourth quarter, Yili Chuanning Bio's performance is expected to improve
- Zhitong · Aug 25, 2025 at 06:53 AM
Yili Chuanning Bio: In the first half of the year, the net profit attributable to the parent company was 455 million yuan, a year-on-year decrease of 40.64%
